Monthly Prescribing Reference

Dry Powder Inhaler Containing Treprostinil Gets FDA Approval

The Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension ...
Monthly Prescribing Reference

Tyvaso Dpi

Treprostinil 16mcg, 32mcg, 48mcg, 64mcg; per cartridge; dry pwd for inh. Ampules (2.9mL)—4; Starter Kit—1 (28 ampules with inhalation system); Refill Kit—1 (28 ampules with accessories); DPI Titration ...
clinicaladvisor.com

Asthma Inhalers: Salbutamol Easyhaler as Effective as Ventolin Evohaler

In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...
Healio

Transition to dry powder inhaled treprostinil safe, tolerable for patients with PAH

Please provide your email address to receive an email when new articles are posted on . The dry powder formulation of treprostinil studied in BREEZE is in development with a reusable breath-powered ...
Nasdaq

MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative therapeutic ...
Healio

FDA approves inhaled treprostinil for treatment of PAH, pulmonary hypertension-ILD

Please provide your email address to receive an email when new articles are posted on . United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of ...
Business Wire

United Therapeutics Announces FDA Approval of Tyvaso DPI™

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the U.S. Food and Drug ...